Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26-week, open-label, randomized, active comparator clinical trial

Zang L.; Liu Y.; Geng J.; Luo Y.; Bian F.; Lv X.; Yang J.; Liu J.; Peng Y.; Li Y.; Sun Y.; Bosch-Traberg H.; Mu Y.

首页> 外文期刊>Diabetes, obesity & metabolism >Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26-week, open-label, randomized, active comparator clinical trial

【24h】

Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26-week, open-label, randomized, active comparator clinical trial

机译：利拉鲁肽与西他列汀联合二甲双胍在中国2型糖尿病患者中的疗效和安全性：一项为期26周，开放标签，随机，有效的对照临床试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: To compare the efficacy and safety of liraglutide versus sitagliptin as add-on to metformin after 26 weeks of treatment in Chinese patients with type 2 diabetes mellitus (T2DM).

机译：目的：比较利拉鲁肽和西他列汀作为二甲双胍在中国2型糖尿病（T2DM）患者治疗26周后的疗效和安全性。

著录项

来源
《Diabetes, obesity & metabolism 》 |2016年第8期| 共9页
作者
Zang L.; Liu Y.; Geng J.; Luo Y.; Bian F.; Lv X.; Yang J.; Liu J.; Peng Y.; Li Y.; Sun Y.; Bosch-Traberg H.; Mu Y.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病 ;
关键词
Chinese; liraglutide; sitagliptin; type 2 diabetes;

机译：中药;利拉鲁肽;西他列汀;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26-week, open-label, randomized, active comparator clinical trial [J] . Zang L., Liu Y., Geng J., Diabetes, obesity & metabolism . 2016 ,第8期

机译：利拉鲁肽与西他列汀联合二甲双胍在中国2型糖尿病患者中的疗效和安全性：一项为期26周，开放标签，随机，有效的对照临床试验
2. Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes a randomized, open-label trial [J] . PratleyR.E., NauckM.A., BaileyT., Diabetes care . 2012 ,第10期

机译：在二甲双胍治疗的2型糖尿病患者中，在52周后从DPP-4抑制剂西他列汀转换为人GLP-1类似物利拉鲁肽的疗效和安全性是一项随机，开放标签试验
3. Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes [J] . FonsecaV., StaelsB., MorganIIJ.D., Journal of diabetes and its complications . 2013 ,第2期

机译：西他列汀在2型糖尿病患者中进行的一项随机，安慰剂对照，为期26周的试验中，将西他列汀与正在进行的二甲双胍和吡格列酮联合治疗的疗效和安全性相结合
4. Clinical efficacy and safety of native bio-absorbable polymer Rapamycin-eluting stent (Excel stent) for Chinese patients with coronary artery disease [C] . Yanmin Xu, Guangping Li, Li Yin, International Congress on Coronary Artery Disease . 2009

机译：生物可吸收聚合物雷帕霉素洗脱支架（Excel支架）对冠心病患者的临床疗效和安全性
5. Efficacy and safety of novel collagen conduits filled with collagen filaments to treat patients with peripheral nerve injury: A multicenter, controlled, open-label clinical trial [D] . Saeki Masaomi, 佐伯将臣 2019

机译：充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性：一项多中心，对照，开放标签的临床试验
6. Efficacy and safety of liraglutide versus sitagliptin both in combination with metformin in Chinese patients with type 2 diabetes: a 26‐week open‐label randomized active comparator clinical trial [O] . L. Zang, Y. Liu, J. Geng, -1

机译：利拉鲁肽与西他列汀联合二甲双胍在中国2型糖尿病患者中的疗效和安全性：一项为期26周开放标签随机有效的对照临床试验
7. Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26‐week, open‐label, randomized, active comparator clinical trial [O] . L. Zang, Y. Liu, J. Geng, 2016

机译：Liraglutide对SitaGlittin的疗效和安全性，两者与二甲双胍联合，中国2型糖尿病患者：26周，开放标签，随机，活性比较术临床试验

Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26-week, open-label, randomized, active comparator clinical trial

摘要

著录项

相似文献

相关主题

期刊订阅